株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の再生医療市場規模調査:技術別、用途別、および地域別予測

Global Regenerative Medicine Market Size study, by Technology, by Application and Regional Forecasts 2019-2026

発行 Bizwit Research & Consulting LLP 商品コード 876664
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
世界の再生医療市場規模調査:技術別、用途別、および地域別予測 Global Regenerative Medicine Market Size study, by Technology, by Application and Regional Forecasts 2019-2026
出版日: 2019年06月25日 ページ情報: 英文
概要

当レポートでは世界の再生医療市場について調査しており、市場機会、技術・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

第1章 エグゼクティブサマリー

  • 市場のスナップショット
  • 主要傾向
  • 全体およびセグメント別市場予測
    • 技術別
    • 用途別
    • 地域別
  • 調査方法
  • 調査の前提条件

第2章 再生医療市場の定義と範囲

  • 研究の目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 研究のために考慮された年
  • 為替レート

第3章 再生医療市場のダイナミクス

  • シーソー分析
    • 市場成長要因
    • 市場の課題
    • 市場機会

第4章 再生医療市場の業界分析

  • ポーターのファイブフォース分析
    • バイヤーの交渉力
    • サプライヤーの交渉力
    • 新規参入の脅威
    • 代用品の脅威
    • 業界内の競争
    • ポーターのファイブフォース分析への将来的アプローチ
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
  • 主な購入基準(オンデマンド)
  • 規制の枠組み(オンデマンド)
  • 投資/導入シナリオ(オンデマンド)
  • アナリストの提言と結論

第5章 再生医療市場:技術別

  • 市場のスナップショット
  • 市場実績 - ポテンシャルモデル
  • 主要市場参入企業
  • 再生医療市場、サブセグメント分析
    • 幹細胞療法
    • バイオマテリアル
    • 生体組織工学
    • その他

第6章 再生医療市場:用途別

  • 市場のスナップショット
  • 市場実績 - ポテンシャルモデル
  • 主要市場参入企業
  • 再生医療市場、サブセグメント分析
    • 骨移植代用品
    • 骨関節疾患
    • 皮膚科
    • 心血管
    • 中枢神経系
    • その他

第7章 再生医療市場:地域別

  • 再生医療市場、地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • その他の欧州
  • アジア
    • 中国
    • インド
    • 日本
    • その他のアジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の世界の地域
    • 南米
    • 中東およびアフリカ

第8章 競合情勢

  • 企業の市場シェア(データの入手可能性別)
  • トップ市場戦略
  • 企業プロファイル
    • Acelity L.P. Inc.
    • Nuvasive Inc.
    • Vericel Corporation
    • Osiris Therapeutics Inc.
    • Stryker Corporation
    • Medtronic PLC

第9章 調査方法

  • 調査方法
    • データマイニング
    • 分析
    • 市場予測
    • 検証
    • 出版
    • 調査の前提条件
図表

List of Tables

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF REGENERATIVE MEDICINE MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF REGENERATIVE MEDICINE MARKET
  • TABLE 3. REGENERATIVE MEDICINE MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
  • TABLE 8. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 9. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 10. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 51. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 56. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 61. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 62. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 66. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 67. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 68. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 69. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 71. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 72. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 73. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 76. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 77. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 78. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 81. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 82. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 83. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 84. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 86. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 87. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 88. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 89. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 91. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 92. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 93. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 94. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 96. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 97. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 98. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 99. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 100. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 101. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 102. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 103. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 104. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 105. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 106. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 107. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 108. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 109. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

List of Figures

  • FIG 1. REGENERATIVE MEDICINE MARKET, RESEARCH METHODOLOGY
  • FIG 2. REGENERATIVE MEDICINE MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. REGENERATIVE MEDICINE MARKET, KEY TRENDS 2017
  • FIG 5. REGENERATIVE MEDICINE MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. REGENERATIVE MEDICINE MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. REGENERATIVE MEDICINE MARKET, PEST ANALYSIS
  • FIG 8. REGENERATIVE MEDICINE MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 20. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 21. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 22. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 23. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 24. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 25. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 26. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 27. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 28. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 29. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 30. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 31. REGENERATIVE MEDICINE MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
  • FIG 33. EUROPE REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
  • FIG 34. ASIA PACIFIC REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
  • FIG 35. LATIN AMERICA REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
  • FIG 36. REGENERATIVE MEDICINE MARKET, COMPANY MARKET SHARE ANALYSIS (2017)
目次

Global Regenerative Medicine Market valued approximately USD 49.68 billion in 2018 is anticipated to grow with a healthy growth rate of more than 24.2% over the forecast period 2019-2026. The Regenerative Medicine Market is continuously growing in the global scenario at significant pace. Regenerative medicines are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or natural aging process. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications. Stem cells are capable of proliferation and differentiation, which increase their importance in this field. Government & private funding to support the development of regenerative medicine, surging prevalence of chronic diseases & genetic disorders, escalating healthcare expenditure and rising geriatric population are the substantial driving factors of the market during the forecast period. Moreover, surging demand for organ transplantation and rising advancements in regenerative medicine is the factors that likely to create numerous opportunity in the near future. However, lack of clear regulatory guidelines and high cost of the treatment through the use of regenerative medicine are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global Regenerative Medicine Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share with nearly 31.3% due to rapid technological advancements and high investment & funding to support development of regenerative medicines in the region. Europe is also estimated to grow at stable growth rate in the global Regenerative Medicine market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to rising development of healthcare infrastructure and presence of large number of patients in the region.

The major market player included in this report are:

Acelity L.P. Inc.

Nuvasive Inc.

Vericel Corporation

Osiris Therapeutics Inc.

Stryker Corporation

Medtronic PLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

Stem Cell Therapy

Biomaterial

Tissue Engineering

Others

By Application:

Bone Graft Substitutes

Osteoarticular Diseases

Dermatology

Cardiovascular

Central Nervous System

Others

By Regions:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Regenerative Medicine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Regenerative Medicine Market, by Technology, 2016-2026 (USD Billion)
    • 1.3.2. Regenerative Medicine Market, by Application, 2016-2026 (USD Billion)
    • 1.3.3. Regenerative Medicine Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Regenerative Medicine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Regenerative Medicine Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Regenerative Medicine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Regenerative Medicine Market, by Technology

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Regenerative Medicine Market, Sub Segment Analysis
    • 5.4.1. Stem Cell Therapy
      • 5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.2. Biomaterial
      • 5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.3. Tissue Engineering
      • 5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Regenerative Medicine Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Regenerative Medicine Market, Sub Segment Analysis
    • 6.4.1. Bone Graft Substitutes
      • 6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.2. Osteoarticular Diseases
      • 6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.3. Dermatology
      • 6.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.4. Cardiovascular
      • 6.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.5. Central Nervous System
      • 6.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.6. Others
      • 6.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Regenerative Medicine Market, by Regional Analysis

  • 7.1. Regenerative Medicine Market, Regional Market Snapshot (2016-2026)
  • 7.2. North America Regenerative Medicine Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.1.3. Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.2.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.3. Europe Regenerative Medicine Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.3.3. Rest of Europe
      • 7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.4. Asia Regenerative Medicine Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.5. Latin America Regenerative Medicine Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.5.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.6.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Acelity L.P. Inc.
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. Nuvasive Inc.
    • 8.3.3. Vericel Corporation
    • 8.3.4. Osiris Therapeutics Inc.
    • 8.3.5. Stryker Corporation
    • 8.3.6. Medtronic PLC

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption
Back to Top